![William Tente](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Tente
Corporate Officer/Principal chez
TIZIANA LIFE SCIENCES LTD
Profil
William E.
Tente is Chief Regulatory Officer at Humacyte Global, Inc. since 2018 and Chief Regulatory Officer at Tiziana Life Sciences Ltd. Former roles include Chief Regulatory Officer at Humacyte, Inc. from 2021 to 2022; Vice President-Operations at Neurotech USA, Inc. from 2002 to 2007; Operations Director at Chimeric Therapies, Inc. from 1998 to 2002; Director-Clinical Production at CytoTherapuetics, Inc. from 1992 to 1998; Vice President-Operations at Neurotech Pharmaceuticals, Inc. (United States); and Principal at Schering Biotech Corp., Ares-Serono Group, and Charles River Biotechnical Services, Inc. Education includes undergraduate and graduate degrees from the University of Rhode Island.
Postes actifs de William Tente
| Sociétés | Poste | Début |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Corporate Officer/Principal | - |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Conseiller Juridique Général | 01/01/2008 |
Anciens postes connus de William Tente
| Sociétés | Poste | Fin |
|---|---|---|
| HUMACYTE, INC. | Conseiller Juridique Général | 20/09/2022 |
Neurotech USA, Inc. | Directeur des opérations | 01/08/2007 |
Chimeric Therapies, Inc. | Directeur des opérations | 01/06/2002 |
CytoTherapuetics, Inc.
 CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Corporate Officer/Principal | 01/01/1998 |
Schering Biotech Corp. | Corporate Officer/Principal | - |
Formation de William Tente
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Schering Biotech Corp. | |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Designs and develops therapeutic systems for retinal diseases | Health Technology |
CytoTherapuetics, Inc.
CytoTherapuetics, Inc. Financial ConglomeratesFinance Biological Products | Finance |
Ares-Serono Group
 Ares-Serono Group Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Charles River Biotechnical Services, Inc. | |
Chimeric Therapies, Inc. | |
Neurotech USA, Inc. | Electronic Technology |
Humacyte, Inc.
 Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
